ALLMedicine™ Urticaria Center
Research & Reviews 1,854 results
Immunotherapy Del Río PR, Fernández FR et. al.
Dec 2nd, 2021 - Management guidelines for allergic rhinitis and urticaria recommend oral second-generation antihistamines as first-line treatment. The efficacy and safety of bilastine, the newest nonsedating second-generation antihistamine, are well established i...
Cutis Kowtoniuk RA, Liu YE et. al.
Dec 1st, 2021 - Service members of the US Military are at risk for cutaneous cold weather injuries due to the demands of military training, combat operations, and peacekeeping missions. In this article, we review common cutaneous cold weather injuries likely to b...
Clinics in Dermatology; Shao K, Feng H
Nov 27th, 2021 - Urticaria is a distressing dermatologic condition for many. Although the wheals of urticaria are characteristically evanescent, lasting less than 24 hours, patients tend to have recurrent episodes. Hives that last less than 6 weeks are considered ...
International Journal of Dermatology; Podder I, Jaiswal S et. al.
Nov 27th, 2021 - Although the relationship between diet and chronic spontaneous urticaria (CSU) remains elusive, several patients seek dietary modifications as they are easy and cost-effective. Adequate patient education and counseling are crucial as modified diet...
Dermatologic Therapy; Pourani MR, Shahidi Dadras M et. al.
Nov 26th, 2021 - Considering the emergency approval of the Food and Drug Administration for widespread use of coronavirus disease 2019 (COVID-19) vaccines, evaluating potential vaccine-related adverse effects is critical as it will allow physicians to diagnose and...
Guidelines 6 results
Allergy Vultaggio A, Agache I et. al.
Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...
Allergy Zuberbier T, Aberer W et. al.
Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...
Allergy Zuberbier T, Aberer W et. al.
Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F
Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...
Allergy Zuberbier T, Asero R et. al.
Sep 24th, 2009 - This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: definition, classification and diagno...
Drugs 822 results see all →
Clinicaltrials.gov 78 results
Nov 11th, 2021 - The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).
Oct 6th, 2021 - The aim of this study is to investigate the use of benralizumab as treatment for patients with chronic spontaneous urticaria (CSU) who are symptomatic despite the use of antihistamines. It is proposed that benralizumab will deplete eosinophils and...
Sep 17th, 2021 - This is a Phase 3 multi-center, open-label, single arm study investigating the safety, tolerability and efficacy of remibrutinib in participants with CSU inadequately controlled by second generation H1-antihistamines. Inadequate control of CSU by ...
Sep 16th, 2021 - This is a multicenter, randomized, double-blind study to demonstrate similar efficacy and safety of TEV-45779 compared to XOLAIR administered sc at doses of 300 mg or 150 mg every 4 weeks for 24 weeks (6 treatments) in patients with Chronic Idiopa...
Sep 9th, 2021 - The purpose of the study is to assess safety, tolerability and pharmacokinetics (PK) of oral UCB8600.
News 269 results
Ashley Ng, BS, Amber Reck Atwater, MD et. al.
Nov 8th, 2021 - Topical medications frequently are prescribed in dermatology and provide the advantages of direct skin penetration and targeted application while typically sparing patients from systemic effects. Adverse cutaneous effects include allergic contact.
Oct 6th, 2021 - The high affinity CD47 myeloid checkpoint inhibitor ALX148 showcased favorable safety and elicited objective responses when combined with trastuzumab (Herceptin), pembrolizumab (Keytruda), and multiagent chemotherapy regimens in patients with gast...
Oct 5th, 2021 - It is estimated that one million people in the UK are currently living with long COVID, and with the total number of UK COVID-19 cases nearing 8 million, the further implications of long COVID for patients and healthcare services is uncertain. As ...
Sep 22nd, 2021 - Irish dermatologists are reporting two more cases of a rare skin ulcer known as reactive infectious mucocutaneous eruption (RIME) in teenage males who were infected with COVID-19. A similar case in an adolescent, also with ulcers affecting the mou...
Sep 9th, 2021 - Most adverse events associated with the practice of microneedling are transient, and most adverse effects and allergic reactions occur in conjunction with combination therapies, according to the results of a systematic review of nearly 3,000 patie...